Literature DB >> 35034322

A Combined In Vitro and In Vivo Assessment of the Safety of the Yeast Strains Kluyveromyces marxianus A4 and A5 Isolated from Korean Kefir.

Hye-Young Youn1, Dong-Hyeon Kim1, Hyeon-Jin Kim1, Yong-Seok Jang1, Kwang-Young Song1, Dongryeoul Bae1, Hyunsook Kim2, Kun-Ho Seo3.   

Abstract

Kefir is a traditional fermented milk containing beneficial bacteria and yeasts. Despite Kluyveromyces marxianus, isolated from kefir, gaining increasing attention as a potential probiotic yeast owing to its biological function, Saccharomyces boulardii is the only species considered as a probiotic yeast. We evaluated the safety of K. marxianus strains A4 and A5, isolated from Korean kefir, in comparison with that of S. boulardii. Virulence attributes were preliminarily assessed in vitro including their ability of gelatin hydrolysis, pseudohyphae formation, and hemolysis. To evaluate in vivo safety, the strains were challenged in a healthy animal model, four-week-old female BALB/c mice. Mice were orally administered 0.2 mL of 0.9% sterilized saline (NC_S; n = 6), S. boulardii ATCC MYA-796 (high concentration, S.b_H; low concentration, S.b_L; n = 6 for each), K. marxianus A4 (high concentration, A4_H; low concentration, A4_L; n = 6 for each), or K. marxianus A5 (high concentration, A5_H; low concentration, A5_L; n = 6 for each) for 2 weeks. At study end, body weight, spleen and liver weights, and blood parameters were assessed. K. marxianus A4 and A5 were tested negative for gelatinase and hemolysis. Overall, hematological, plasma biochemical, and cytokine (interleukin-1β and tumor necrosis factor-α) parameters were comparable between the experimental and negative control (NC) groups. Notably, the interleukin-6 level of the A5_H group was significantly lower than that of the NC group (p < 0.05), suggesting anti-inflammatory potential of K. marxianus A5.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Kefir yeast; Kluyveromyces marxianus; Probiotics; Safety assessment

Year:  2022        PMID: 35034322     DOI: 10.1007/s12602-021-09872-7

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  32 in total

Review 1.  Possible role of catheters in Saccharomyces boulardii fungemia.

Authors:  C Hennequin; C Kauffmann-Lacroix; A Jobert; J P Viard; C Ricour; J L Jacquemin; P Berche
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-01       Impact factor: 3.267

Review 2.  Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials.

Authors:  Sunil Sazawal; Girish Hiremath; Usha Dhingra; Pooja Malik; Saikat Deb; Robert E Black
Journal:  Lancet Infect Dis       Date:  2006-06       Impact factor: 25.071

3.  Selection of potential probiotic lactic acid bacteria from fermented olives by in vitro tests.

Authors:  Anthoula A Argyri; Georgia Zoumpopoulou; Kimon-Andreas G Karatzas; Effie Tsakalidou; George-John E Nychas; Efstathios Z Panagou; Chrysoula C Tassou
Journal:  Food Microbiol       Date:  2012-10-31       Impact factor: 5.516

4.  Yeasts from kefir grains: isolation, identification, and probiotic characterization.

Authors:  Gabriela Diosma; David E Romanin; María F Rey-Burusco; Alejandra Londero; Graciela L Garrote
Journal:  World J Microbiol Biotechnol       Date:  2013-07-04       Impact factor: 3.312

Review 5.  Probiotic use in clinical practice: what are the risks?

Authors:  Robert J Boyle; Roy M Robins-Browne; Mimi L K Tang
Journal:  Am J Clin Nutr       Date:  2006-06       Impact factor: 7.045

Review 6.  Safety assessment of probiotics for human use.

Authors:  Mary Ellen Sanders; Louis M A Akkermans; Dirk Haller; Cathy Hammerman; James Heimbach; Gabriele Hörmannsperger; Geert Huys; Dan D Levy; Femke Lutgendorff; David Mack; Phoukham Phothirath; Gloria Solano-Aguilar; Elaine Vaughan
Journal:  Gut Microbes       Date:  2010-03-04

7.  Review article: yeast as probiotics -- Saccharomyces boulardii.

Authors:  D Czerucka; T Piche; P Rampal
Journal:  Aliment Pharmacol Ther       Date:  2007-09-15       Impact factor: 8.171

8.  Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome.

Authors:  Mary Ann De Groote; Daniel N Frank; Elaine Dowell; Mary P Glode; Norman R Pace
Journal:  Pediatr Infect Dis J       Date:  2005-03       Impact factor: 2.129

9.  Safety evaluation of arachidonic acid rich Mortierella alpina biomass in albino rats--a subchronic study.

Authors:  A Nisha; S P Muthukumar; G Venkateswaran
Journal:  Regul Toxicol Pharmacol       Date:  2009-01-19       Impact factor: 3.271

10.  The antimicrobial properties of different strains of Lactobacillus spp. isolated from kefir.

Authors:  A Santos; M San Mauro; A Sanchez; J M Torres; D Marquina
Journal:  Syst Appl Microbiol       Date:  2003-09       Impact factor: 4.022

View more
  1 in total

1.  Survivability of Kluyveromyces marxianus Isolated From Korean Kefir in a Simulated Gastrointestinal Environment.

Authors:  Hye-Young Youn; Dong-Hyeon Kim; Hyeon-Jin Kim; Dongryeoul Bae; Kwang-Young Song; Hyunsook Kim; Kun-Ho Seo
Journal:  Front Microbiol       Date:  2022-02-24       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.